Because p53 inactivation leads to pro-tumor chronic inflammation and immunosuppression in the TME, we hypothesize that p53 activation or restoration in the TME reverses immunosuppression and reshapes the immunological landscape to support productive antitumor immunity for better tumor control. This evidence concerns the gene TP53 and neoplasm.